Next, we examined the therapeutic effects of LX/IL-24-modified tumor vaccines, and significant inhibition of tumor growth was observed after being treated with LX/IL-24-modified tumor vaccines, indicating the production of IL-24 by NDV-infected vaccine cells may enhance antitumor effects. Here, IL24 is linked to neoplasm.